Oligopeptides as full-length New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors

PLoS ONE

Volumn 12, Issue 5, 2017, Pages

  Shen, Bingzheng ^a,b   Zhu, Chengliang ^a   Gao, Xiang ^a   Liu, Gang ^a   Song, Jinchun ^a   Yu, Yan ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; ERTAPENEM; MEROPENEM; METALLO BETA LACTAMASE; NEW DELHI METALLO BETA LACTAMASE 1; OLIGOPEPTIDE; OLIGOPEPTIDE 1; OLIGOPEPTIDE 10; OLIGOPEPTIDE 2; OLIGOPEPTIDE 3; OLIGOPEPTIDE 4; OLIGOPEPTIDE 5; OLIGOPEPTIDE 6; OLIGOPEPTIDE 7; OLIGOPEPTIDE 8; OLIGOPEPTIDE 9; PENICILLIN G; PIPERACILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE; BETA-LACTAMASE NDM-1; ENZYME INHIBITOR; ION; PROTEIN BINDING; WATER; ZINC;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BINDING; DRUG DESIGN; DRUG POTENTIATION; ENZYME INHIBITION; ESCHERICHIA COLI; GENETIC ENGINEERING; HYDROGEN BOND; IC50; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DOCKING; NONHUMAN; PSEUDOMONAS AERUGINOSA; STATIC ELECTRICITY; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME ACTIVE SITE; METABOLISM;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; CATALYTIC DOMAIN; DRUG SYNERGISM; ENZYME INHIBITORS; ESCHERICHIA COLI; HYDROGEN BONDING; IONS; MOLECULAR DOCKING SIMULATION; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; STATIC ELECTRICITY; WATER; ZINC;

EID: 85019624630     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0177293     Document Type: Article

References (30)

1. Gupta K, Martinello RA, Young M, Strymish J, Cho K, Lawler E. MRSA nasal carriage patterns and the subsequent risk of conversion between patterns, infection, and death. PLoS One. 2013; 8: e53674. https://doi.org/10.1371/journal.pone.0053674 PMID: 23326483
2. Ahmed-Bentley J, Chandran AU, Joffe AM, French D, Peirano G, Pitout JD. Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother. 2013; 57: 3085-91. https://doi.org/10.1128/AAC.00297-13 PMID: 23612195
3. Hoesly FJ, Baker SG, Gunawardane ND, Cotliar JA. Capecitabine-induced hand-foot syndrome complicated by pseudomonal superinfection resulting in bacterial sepsis and death: case report and review of the literature. Arch Dermatol. 2011; 147:1418-23. https://doi.org/10.1001/archdermatol.2011.320 PMID: 22184763
4. Giedraitiene A, Vitkauskiene A, Naginiene R, Pavilonis A. Antibiotic resistance mechanisms of clinically important bacteria. Medicina (Kaunas). 2011; 47:137-146.
5. Wickens H, Wade P. Understanding antibiotic resistance. Pharmaceutical journal 2005; 274: 501-504.
6. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its corre-lation with molecular structure. Antimicrob Agents Chemother. 1995; 39:1211-33. PMID: 7574506
7. Bush K, Jacoby GA. Updated functional classification of (3-lactamases. Antimicrob Agents Chemother. 2010; 54: 969-76. https://doi.org/10.1128/AAC.01009-09 PMID: 19995920
8. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009; 53: 5046-54. https://doi.org/10.1128/AAC.00774-09 PMID: 19770275
9. Wailan AM, Paterson DL. The spread and acquisition of NDM-1: a multifactorial problem, Expert Rev Anti Infect Ther. 2014; 12: 91-115. https://doi.org/10.1586/14787210.2014.856756 PMID: 24308710
10. Fischer J, Schmoger S, Jahn S, Helmuth R, Guerra B. NDM-1 carbapenemase-producing Salmonella enterica subsp. enterica serovar Corvallis isolated from a wild bird in Germany. J Antimicrob Chemother. 2013; 68: 2954-6. https://doi.org/10.1093/jac/dkt260 PMID: 23818284
11. Zhang WJ, Lu Z, Schwarz S, Zhang RM, Wang XM, Si W, et al. Complete sequence of the bla(NDM-1)-carrying plasmid pNDM-AB from Acinetobacterbaumanniiof food animal origin. J Antimicrob Chemother. 2013; 68:1681-2. https://doi.org/10.1093/jac/dkt066 PMID: 23449827
12. Wang Y, Wu C, Zhang Q, Qi J, Liu H, Wang Y, et al. Identification of New Delhi metallo-(3-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS One. 2012; 7: e37152. https://doi.org/10.1371/journal.pone.0037152 PMID: 22629360
13. Guenther S, Ewers C, Wieler LH. Extended-Spectrum Beta-Lactamases Producing E. coli in Wildlife, yet Another Form of Environmental Pollution? Front Microbiol. 2011; 2:246. https://doi.org/10.3389/fmicb.2011.00246 PMID: 22203818
14. Toleman MA, Spencer J, Jones L, Walsh TR. blaNDM-1 is a chimera likely constructed in Acinetobacter baumannii. Antimicrob Agents Chemother. 2012; 56:2773-6. https://doi.org/10.1128/AAC.06297-11 PMID: 22314529
15. Zhang H, Hao Q. Crystal structure of NDM-1 reveals a common (3-lactam hydrolysis mechanism, FASEB J. 2011; 25: 2574-82. https://doi.org/10.1096/fj.11-184036 PMID: 21507902
16. Kim Y, Tesar C, Mire J, Jedrzejczak R, Binkowski A, Babnigg G, et al. Structure of apo-and monometa-lated forms of NDM-1-a highly potent carbapenem-hydrolyzing metallo-(3-lactamase. PLoS One. 2011; 6: e24621. https://doi.org/10.1371/journal.pone.0024621 PMID: 21931780
17. King D, Strynadka N. Crystal structure of New Delhi metallo-(3-lactamase reveals molecular basis for antibiotic resistance. Protein Sci. 2011; 20:1484-91. https://doi.org/10.1002/pro.697 PMID: 21774017
18. Clinical and Laboratory Standards Institute. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 23rd informational supplement CLSI. Wayne, PA. 2013; M100-S23.
19. Shen B, Yu Y, Chen H, Cao X, Lao X, Fang Y, et al. Inhibitor Discovery of Full-Length New Delhi Metallo-(3-Lactamase-1 (NDM-1). PLoS One. 2013; 8: e62955. https://doi.org/10.1371/journal.pone. 0062955 PMID: 23675445
20. Laraki N, Franceschini N, Rossolini GM, Santucci P, Meunier C, de Pauw E, et al. Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-(3-Lactamase IMP-1 Produced by Escherichia coli. Antimicrob Agents Chemother. 1999; 43: 902-6. PMID: 10103197
21. Musson DG, Birk KL, Kitchen CJ, Zhang J, Hsieh JY, Fang W, et al. Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 783:1-9. PMID: 12450519
22. Samuelsen 0, Castanheira M, Walsh TR, Spencer J. Kinetic characterization of VIM-7, a divergent member of the VIM metallo-(3-lactamase family. Antimicrob Agents Chemother. 2008; 52:2905-8. https://doi.org/10.1128/AAC.00166-08 PMID: 18559652
23. Poirel L, Bonnin RA, Nordmann P. Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing. Antimicrob Agents Chemother. 2011; 55:4224-9. https://doi.org/10.1128/AAC.00165-11 PMID: 21746951
24. Hammond GG, Huber JL, Greenlee ML, Laub JB, Young K, Silver LL, et al. Inhibition of IMP-1 metallo-(3-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives. FEMS Microbiol Lett. 1999; 179:289-96. PMID: 10518728
25. Moloughney JG, Thomas J D, Toney JH. Novel IMP-1 metallo-(3-lactamase inhibitors can reverse mero-penem resistance in Escherichia coli expressing IMP-1. FEMS Microbiol Lett. 2005; 243: 65-71. https://doi.org/10.1016/j.femsle.2004.11.042 PMID: 15668002
26. Discovery Studio Version 2.5 User Manual. Accelrys Inc, San Diego, CA. 2009.
27. Chen J, Chen H, Shi Y, Hu F, Lao X, Gao X, et al. Probing the Effect of the Non-Active-Site Mutation Y229W in New Delhi Metallo-(3-lactamase-1 by Site-Directed Mutagenesis, Kinetic Studies, and Molecular Dynamics Simulations. PLoS One. 2013; 8: e82080. https://doi.org/10.1371/journal.pone.0082080 PMID: 24339993
28. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: A program for macromolecular energy minimization and dynamics calculations. J Comp Chem. 1983; 4:187-217.
29. Nix DE, Majumdar AK, DiNubile MJ. Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. J Antimicrob Chemother. 2004; 53 Suppl 2:ii23-8.
30. Burley SK, Petsko GA. Amino-aromatic interactions in proteins. FEBS Lett. 1986; 203:139-143. PMID: 3089835